文献速递腹部MR

钆塞酸二钠给药后急性短暂性呼吸困难及相关伪影发生率评估:一项前瞻性观察性研究

Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
PubMed 文献 · Radiol Med · 2018-08-06

该前瞻性观察性研究纳入250例连续患者,采用多动脉期技术行钆塞酸二钠增强肝脏MR检查,监测血氧饱和度和心率并评估屏气情况。结果显示屏气失败和急性短暂性呼吸困难主要见于第三动脉期,运动伪影发生率从第一动脉期的2.9%升至第三动脉期的19.5%(p<0.0001),但所有患者均获得至少一个无运动伪影且采集时机合适的动脉期图像。

要点

  • 运动伪影发生率第一动脉期2.9%、第二动脉期4.0%、第三动脉期19.5%(p<0.0001)。
  • PACE监测显示16/250例(6.4%)屏气异常,仅2例(0.8%)自报急性短暂性呼吸困难。
  • 所有患者均获得至少一个无运动伪影且采集时机合适的动脉期图像。

核心结论

  • 钆塞酸二钠给药后屏气失败和急性短暂性呼吸困难的发生率仅在第三动脉期升高,但本方案使所有患者均获得至少一个无运动伪影且采集时机合适的动脉期图像。

研究设计与样本

  • 经机构审查委员会批准的前瞻性观察性研究,纳入250例连续患者,采用多动脉期技术行钆塞酸二钠增强肝脏MR检查,监测血氧饱和度和心率,用PACE监测评估屏气,由三名读者独立分析所有图像判断运动伪影,使用非参数统计检验和Fleiss kappa。

关键影像表现/征象

  • 运动伪影在钆塞酸二钠采集的第三动脉期增加最明显(p<0.0001)。
  • 运动伪影发生率第一动脉期为2.9%,第二动脉期为4.0%,第三动脉期为19.5%。
  • 运动伪影增加主要归因于患者无法在整个检查期间屏气。

诊断标准与关键数值

  • PACE图显示16/250例(6.4%)屏气异常。
  • 6例患者在检查过程中自报症状,其中仅2例(0.8%)发生急性短暂性呼吸困难。
  • 整个MR检查期间血氧饱和度和心率值无统计学差异。

临床应用与阅片要点

  • 阅片时注意第三动脉期运动伪影发生率较高(19.5%),需结合其他动脉期图像综合判断。
  • 本方案确保所有患者至少有一个无运动伪影且采集时机合适的动脉期图像可供诊断使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: To evaluate motion artifacts, breath-hold failure, acute transient dyspnea, and clinical parameters during hepatic arterial phase of gadoxetate disodium-enhanced magnetic resonance (MR) imaging.

METHODS: This was an institutional review board-approved observational prospective study (written informed consent acquired) performed in 250 consecutive patients, who underwent liver MR with a multiarterial phase technique. Oxygen saturation (SatO2) and heart rate (HR) were monitored, while patients reported subjective symptoms. Breath-holds were assessed using prospective acquisition correction technique (PACE) monitors. Three readers independently analyzed all images to establish the presence of motion artifacts. Nonparametric statistical testing and Fleiss' kappa were used.

RESULTS: No statistical differences in SatO2 and HR values were observed during the entire length of MR examination. The PACE graphs showed an altered breath-hold in 16/250 patients (6.4%), however only 6 patients self-reported symptoms during the procedure, and among these 6 subjects, only 2 suffered from acute transient dyspnea (0.8%). Motion-related artifacts increased mostly in the third arterial phase of gadoxetate disodium acquisition (p < 0.0001): The artifacts incidence was 2.9% in the first phase; 4.0% in the second; and 19.5% in the third. This increase was mainly due to patients' inability to hold their breath for the entire duration of the examination. However, at least one gadoxetate disodium arterial phase without motion artifacts and adequate for acquisition timing, was acquired in all MR examinations.

CONCLUSION: The incidence of breath-hold failure and acute transient dyspnea after gadoxetate disodium administration increased during the third arterial phase only. Our protocol allowed the acquisition of at least one arterial phase not compromised by motion artifacts and adequate for acquisition timing, in all patients.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Grazioli L, Faletti R, Frittoli B, et al. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study. Radiol Med. 2018. PMID: 30084108. doi:10.1007/s11547-018-0927-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。